Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 455

1.

In vitro bioassays to evaluate beneficial and adverse health effects of botanicals: promises and pitfalls.

Prinsloo G, Papadi G, Hiben MG, de Haan L, Louisse J, Beekmann K, Vervoort J, Rietjens IMCM.

Drug Discov Today. 2017 May 19. pii: S1359-6446(17)30024-7. doi: 10.1016/j.drudis.2017.05.002. [Epub ahead of print] Review.

PMID:
28533190
2.

The associations between childhood trauma, neuroticism and comorbid obsessive-compulsive symptoms in patients with psychotic disorders.

Schreuder MJ, Schirmbeck F, Meijer C, de Haan L; GROUP Investigators..

Psychiatry Res. 2017 Apr 19;254:48-53. doi: 10.1016/j.psychres.2017.04.030. [Epub ahead of print]

PMID:
28448804
3.

Advanced Glycation End Products in Recent-Onset Psychosis Indicate Early Onset of Cardiovascular Risk.

Hagen JM, Sutterland AL, Koeter MW, Lutter R, Cohen D, de Haan L.

J Clin Psychiatry. 2017 Apr 25. doi: 10.4088/JCP.16m10972. [Epub ahead of print]

PMID:
28445633
4.

The role of cognitive functioning in the relationship between childhood trauma and a mixed phenotype of affective-anxious-psychotic symptoms in psychotic disorders.

Mansueto G, van Nierop M, Schruers K; GROUP Investigators., Alizadeh BZ, Bartels-Velthuis AA, van Beveren NJ, Bruggeman R, Cahn W, de Haan L, Delespaul P, Meijer CJ, Myin-Germeys I, Kahn RS, Schirmbeck F, Simons CJP, van Haren NEM, van Os J, van Winkel R.

Schizophr Res. 2017 Apr 13. pii: S0920-9964(17)30190-1. doi: 10.1016/j.schres.2017.04.003. [Epub ahead of print]

PMID:
28416093
5.

Validation of full-field optical coherence tomography in distinguishing malignant and benign tissue in resected pancreatic cancer specimens.

van Manen L, Stegehuis PL, Fariña-Sarasqueta A, de Haan LM, Eggermont J, Bonsing BA, Morreau H, Lelieveldt BPF, van de Velde CJH, Vahrmeijer AL, Dijkstra J, Mieog JSD.

PLoS One. 2017 Apr 17;12(4):e0175862. doi: 10.1371/journal.pone.0175862. eCollection 2017.

6.

MEDI1873, a potent, stabilized hexameric agonist of human GITR with regulatory T-cell targeting potential.

Tigue NJ, Bamber L, Andrews J, Ireland S, Hair J, Carter E, Sridharan S, Jovanović J, Rees DG, Springall JS, Solier E, Li YM, Chodorge M, Perez-Martinez D, Higazi DR, Oberst M, Kennedy M, Black CM, Yan L, Schwickart M, Maguire S, Cann JA, de Haan L, Young LL, Vaughan T, Wilkinson RW, Stewart R.

Oncoimmunology. 2017 Feb 3;6(3):e1280645. doi: 10.1080/2162402X.2017.1280645. eCollection 2017.

7.

Antipsychotic medication and long-term mortality risk in patients with schizophrenia; a systematic review and meta-analysis.

Vermeulen J, van Rooijen G, Doedens P, Numminen E, van Tricht M, de Haan L.

Psychol Med. 2017 Apr 11:1-12. doi: 10.1017/S0033291717000873. [Epub ahead of print]

PMID:
28397632
8.

Nursing Staff Factors Contributing to Seclusion in Acute Mental Health Care - An Explorative Cohort Study.

Doedens P, Maaskant JM, Latour CH, van Meijel BK, Koeter MW, Storosum JG, Barkhof E, de Haan L.

Issues Ment Health Nurs. 2017 Apr 7:1-6. doi: 10.1080/01612840.2017.1297513. [Epub ahead of print]

PMID:
28388296
9.

Comparing the effect of clozapine and risperidone on cue reactivity in male patients with schizophrenia and a cannabis use disorder: A randomized fMRI study.

Machielsen MW, Veltman DJ, van den Brink W, de Haan L.

Schizophr Res. 2017 Mar 25. pii: S0920-9964(17)30168-8. doi: 10.1016/j.schres.2017.03.030. [Epub ahead of print]

PMID:
28351544
10.

Genetic correlation between amyotrophic lateral sclerosis and schizophrenia.

McLaughlin RL, Schijven D, van Rheenen W, van Eijk KR, O'Brien M, Kahn RS, Ophoff RA, Goris A, Bradley DG, Al-Chalabi A, van den Berg LH, Luykx JJ, Hardiman O, Veldink JH; Project MinE GWAS Consortium.; Schizophrenia Working Group of the Psychiatric Genomics Consortium..

Nat Commun. 2017 Mar 21;8:14774. doi: 10.1038/ncomms14774.

11.

A symptom network structure of the psychosis spectrum.

van Rooijen G, Isvoranu AM, Meijer CJ, van Borkulo CD, Ruhé HG, de Haan L; GROUP investigators..

Schizophr Res. 2017 Feb 22. pii: S0920-9964(17)30104-4. doi: 10.1016/j.schres.2017.02.018. [Epub ahead of print]

PMID:
28237606
12.

Obsessive-compulsive symptoms and overall psychopathology in psychotic disorders: longitudinal assessment of patients and siblings.

Schirmbeck F, Swets M, Meijer CJ, Zink M, de Haan L; GROUP investigators..

Eur Arch Psychiatry Clin Neurosci. 2016 Dec 17. [Epub ahead of print]

PMID:
27988852
13.

Homesick: residential and care patterns in patients with severe mental illness.

de Mooij LD, Kikkert M, Lommerse NM, Theunissen J, de Koning MB, de Haan L, Beekman AT, Duurkoop PW, Dekker JJ.

BMC Psychiatry. 2016 Dec 3;16(1):431.

14.

Effect of ω-3 Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders: The NEURAPRO Randomized Clinical Trial.

McGorry PD, Nelson B, Markulev C, Yuen HP, Schäfer MR, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger GE, Chen EY, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, Verma S, Thompson A, Yung AR, Amminger GP.

JAMA Psychiatry. 2017 Jan 1;74(1):19-27. doi: 10.1001/jamapsychiatry.2016.2902.

PMID:
27893018
15.

The effect of childhood adversity on 4-year outcome in individuals at ultra high risk for psychosis in the Dutch Early Detection Intervention Evaluation (EDIE-NL) Trial.

Kraan TC, Ising HK, Fokkema M, Velthorst E, van den Berg DP, Kerkhoven M, Veling W, Smit F, Linszen DH, Nieman DH, Wunderink L, Boonstra N, Klaassen RM, Dragt S, Rietdijk J, de Haan L, van der Gaag M.

Psychiatry Res. 2017 Jan;247:55-62. doi: 10.1016/j.psychres.2016.11.014. Epub 2016 Nov 11.

PMID:
27863320
16.

Cortical Morphology Differences in Subjects at Increased Vulnerability for Developing a Psychotic Disorder: A Comparison between Subjects with Ultra-High Risk and 22q11.2 Deletion Syndrome.

Bakker G, Caan MW, Vingerhoets WA, da Silva-Alves F, de Koning M, Boot E, Nieman DH, de Haan L, Bloemen OJ, Booij J, van Amelsvoort TA.

PLoS One. 2016 Nov 9;11(11):e0159928. doi: 10.1371/journal.pone.0159928. eCollection 2016.

17.

Integrating in vitro data and physiologically based kinetic (PBK) modelling to assess the in vivo potential developmental toxicity of a series of phenols.

Strikwold M, Spenkelink B, de Haan LHJ, Woutersen RA, Punt A, Rietjens IMCM.

Arch Toxicol. 2017 May;91(5):2119-2133. doi: 10.1007/s00204-016-1881-x. Epub 2016 Nov 4.

18.

Adjunctive memantine in clozapine-treated refractory schizophrenia: an open-label 1-year extension study.

Veerman SR, Schulte PF, Deijen JB, de Haan L.

Psychol Med. 2017 Jan;47(2):363-375. doi: 10.1017/S0033291716002476. Epub 2016 Oct 25.

PMID:
27776560
19.

Reduced specialized processing in psychotic disorder: a graph theoretical analysis of cerebral functional connectivity.

Peeters SC, Gronenschild EH, van Amelsvoort T, van Os J, Marcelis M; Genetic Risk and Outcome of Psychosis (G.R.O.U.P.)., Kahn R, Wiersma D, Bruggeman R, Cahn W, de Haan L, Meijer C, Myin-Germeys I.

Brain Behav. 2016 Jun 29;6(9):e00508. eCollection 2016 Sep.

20.

The effect of childhood trauma and Five-Factor Model personality traits on exposure to adult life events in patients with psychotic disorders.

Pos K, Boyette LL, Meijer CJ, Koeter M, Krabbendam L, de Haan L, For Group.

Cogn Neuropsychiatry. 2016 Nov;21(6):462-474. doi: 10.1080/13546805.2016.1236014. Epub 2016 Sep 28.

PMID:
27678148

Supplemental Content

Loading ...
Support Center